AskTheDate.com
Back to calendar

Maze Therapeutics, Inc. (MAZE) Earnings

MAZE reports earnings on Thursday, November 5, 2026

earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.76
Actual EPS: $-0.76
EPS surprise: -5.95%
Company overview
Market Cap$1.5B
PriceUSD 26.72
EPS (TTM)-2.53
52-week high53.65
52-week low14.16
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees141
Buy me a coffee